Skip to main content
. Author manuscript; available in PMC: 2015 Jun 1.
Published in final edited form as: Biochim Biophys Acta. 2014 Mar 12;1841(6):880–887. doi: 10.1016/j.bbalip.2014.03.001

Table 3.

Doppler echocardiographic analysis of Acsl1H−/− hearts 10 weeks after tamoxifen or vehicle (control) induction.

Control
n=7
Acsl1H−/−
n=7 (n=6 for DT)
Vehicle
ET (ms) 51.0 ± 2.9 45.1 ± 1.8
IRT (ms) 16.1 ± 1.8 16.1 ± 1.8
ICT+ET+IRT (ms) 60.4 ± 2.4 65.8 ± 5.4
MPI 0.20 ± 0.06 0.48 ± 0.10*
E (mm/s) 683.3 ± 22.2 564.6 ± 41.6*
A (mm/s) 374.3 ± 35.7 553.0 ± 37.0*
E/A Ratio 1.92 ± 0.18 1.04 ± 0.08*
DT (ms) 19.2 ± 3.7 18.8 ± 4.0

E (early) and A (atrial) ventricular filling velocity; ET, ejection time; IRT, isovolumetric relaxation time; ICT, isovolumetric contraction time; MPI, mean performance index =(ICT+ET+IRT)−ET/ET); DT, mitral deceleration time. Data represent mean ± SEM;

*

p<0.05 (T-test).